Project Grant R01CA279795

Award Date 5/1/24
Completion Date 1/31/29
Dollars Obligated $1.7M
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
This $393,750.00 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund a 5-year research project to explore the fundamental cellular mechanisms driving cellular senescence in macrophages. The key objectives of this research project are to gain a deeper understanding of the cellular and molecular mechanisms underlying senescent macrophage biology. This includes investigating the roles...
This $1,039,863 National Institutes of Health National Institute on Aging project grant funds research at Harvard Medical School to reverse engineer the process of cellular senescence. The research will use new microscopy techniques to observe cell size changes and correlate protein expression and phosphorylation with senescence markers as cells transition from normal to senescent states in vitro and in vivo in young and aged mice. The same induction-maturation-death lifecycle will be studied...
This $674,996 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research by the Sanford Burnham Prebys Medical Discovery Institute (SBP) to determine if targeting the PSGL-1 checkpoint inhibitor can promote the development and/or maintenance of CD8+ T cells essential for anti-tumor responses to PD-1 immune checkpoint blockade (ICB) therapy. The key objectives are to evaluate if PSGL-1 blockade can generate or sustain tumor-specific...
This R03 project grant, awarded by the National Center for Advancing Translational Sciences (NCATS) under CFDA Program 93.350, aims to comprehensively identify metabolic enzymes that control the generation of TCF1+ progenitor CD8+ T cells, which are critical for durable anti-tumor immune responses. The $169,500 award, spanning from September 1, 2024 to August 31, 2026, will fund two key research objectives: Identifying metabolic enzymes whose loss alters T cell differentiation and the TCF1+...
This $693,942 National Institutes of Health National Heart Lung and Blood Institute Project Grant funds research at Northwestern University aimed at elucidating epigenetic modifiers of regulatory T cell function following viral pneumonia. The goal is to establish causal links between DNA methyltransferase activity, the DNMT adapter UHRF1, and DNA hypermethylation signatures in regulatory T cells during aging and their impaired reparative function after severe viral pneumonia. Through three...
This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $1,602,000.00 to The Children's Hospital of Philadelphia Research Institute to develop and optimize a new class of Epigenetic Reprogramming Factors (ERFs) that can target hundreds, thousands, or tens of thousands of DNA regions in a pathway-specific manner. The goal is to leverage this ERF technology to prevent or reverse epigenetic signatures associated...
This Project Grant award of $445,996 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) aims to investigate how mitigating oxidative stress at T cell telomeres can improve the function and efficacy of adoptive cell therapies against cancer. The research, conducted by the University of Pittsburgh, has two key objectives: Determine the mechanistic role of oxidative damage at telomeres on T cell function and how protecting telomeres with an antioxidant protein can...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $190,278 to The Regents of the University of California, San Francisco (UCSF) to investigate the role of transposable elements in septic immune aging. The key objectives of this 5-year project are to: 1) study the dynamics of transposable element de-repression as a function of age and sepsis, 2) employ machine learning to...
This Project Grant award of $506,404.00 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to investigate mechanisms of local and global epigenetic changes that drive senescence and aging-associated phenotypes. Key research objectives include: Examining how enhancers are rewired during senescence and aging, focusing on large enhancer communities or "cliques" and identifying transcription factors that drive their formation....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $192,788 to the University of California, San Diego to conduct a genome-wide screening and analysis of regulators of plasmacytoid dendritic cell (pDC) function and exhaustion. The research aims to gain a comprehensive understanding of the mechanisms that control interferon-I production and exhaustion in pDCs, which are critical innate immune...

PROTEOME-WIDE BASE EDITOR SCREENS TO ASSESS PHOSPHORYLATION SITE FUNCTIONALITY IN IMMUNOSENESCENCE - ABSTRACT WE OFTEN DEPICT SIGNALING PATHWAYS BY A DOZEN OR SO LANDMARK PHOSPHORYLATION EVENTS THAT CULMINATE IN THE TRANSCRIPTION OF A GENE OR INDUCTION OF A PHENOTYPE. IN REALITY, A CASCADE OF HUNDREDS TO THOUSANDS OF PHOSPHORYLATION SITES CREATE DYNAMIC BIOCHEMICAL NETWORKS THAT ORCHESTRATE ESSENTIALLY EVERY CELLULAR PROCESS FROM EXPRESSION OF TRANSCRIPTIONAL PROGRAMS AND CELL PROLIFERATION TO MIGRATION AND CYTOTOXIC EFFECTOR FUNCTIONS. T CELL SIGNALING IS AN IMPORTANT EXAMPLE. SIGNAL TRANSDUCTION THROUGH THE T CELL RECEPTOR AND CO-STIMULATORY MOLECULES IS INCREDIBLY COMPLEX AND LEADS TO IMPORTANT BUT DISTINCT DOWNSTREAM EFFECTS NECESSARY FOR PROPER IMMUNE RESPONSES TO PATHOGENS, CANCER, AND VACCINES. AS HUMANS AGE, T CELL SIGNALING BECOMES DETRIMENTALLY ALTERED, LEADING TO "IMMUNOSENESCENCE" AND LESS EFFICIENT PROTECTION FROM MALIGNANCIES. MASS SPECTROMETRY HAS ENABLED THE PROFILING OF TENS OF THOUSANDS OF PHOSPHORYLATION SITES FROM A DIVERSE RANGE OF CELLS AND TISSUES. UNFORTUNATELY, FUNCTIONALLY CHARACTERIZING THE TENS OF THOUSANDS OF POST-TRANSLATIONAL MODIFICATIONS CELLS USE TO COORDINATE ESSENTIALLY ALL CELLULAR AND ORGANISMAL PROCESSES REMAINS A FUNDAMENTAL CHALLENGE IN BIOLOGY. HERE, WE PROPOSE AN INNOVATIVE TECHNOLOGY THAT WILL ENABLE THE FUNCTIONAL ASSESSMENT OF THOUSANDS OF PHOSPHORYLATION SITES IN HIGH THROUGHPUT. WE WILL EMPLOY CRISPR-MEDIATED BASE EDITORS, WHICH MUTATE CODONS IN GENOMIC DNA, COUPLED TO PHENOTYPIC SCREENS TO PROBE THE SIGNALING EVENTS THAT LEAD TO SPECIFIC T CELL STIMULATION-SPECIFIC GENE EXPRESSION PROGRAMS OR PROLIFERATION RESPONSES. PRELIMINARY DATA FROM OUR LABORATORY STRONGLY SUGGESTS THAT WE CAN FUNCTIONALLY SCREEN TENS OF THOUSANDS OF PHOSPHORYLATION SITES FOR THEIR CONTRIBUTION TO NFAT OR NFKB SIGNALING IN STIMULATED T CELLS. IN THIS PROPOSAL, WE WILL FURTHER OPTIMIZE THIS TECHNOLOGY TO CREATE A ROBUST, RELIABLE SCREENING PLATFORM. TO VALIDATE OUR SCREENING TECHNOLOGY, WE WILL CHARACTERIZE A SUBSET OF PHOSPHORYLATION SITE MUTANTS USING CONVENTIONAL GENOMIC ENGINEERING METHODS TO UNDERSTAND HOW OUR SCREENING PLATFORM COMPARES TO CLASSIC APPROACHES TO STUDY PHOSPHORYLATION SITE FUNCTION, I.E. ONE MUTATION AT A TIME. WE WILL ALSO EXTEND THIS APPROACH TO PRIMARY HUMAN CD8+ T CELLS, TO SHOW THAT WE CAN UNCOUPLE THE SIGNALING EVENTS THAT LEAD TO CELL PROLIFERATION OR EXPRESSION OF THE ACTIVATION/EXHAUSTION MARKER PD1. HIGH THROUGHPUT FUNCTIONAL SCREENING OF PHOSPHORYLATION SITES IN PRIMARY IMMUNE CELLS WILL REVOLUTIONIZE THE WAY WE STUDY SIGNALING PATHWAYS AND CELLULAR DECISION MAKING, AND THE WAY WE APPROACH DRUG DEVELOPMENT OR ADOPTIVE CELL THERAPIES TO TREAT CANCER AND A VARIETY OF HUMAN AILMENTS ASSOCIATED WITH AGING.

Posted 4/9/24, 12:00 AM